Pathstone Family Office »

Cognition Therapeutics shares owned by Pathstone Family Office

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Pathstone Family Office from 13F filings

Historical chart of Pathstone Family Office investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Pathstone Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Pathstone Family Office

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.2M 2.2M 1.44
2023-06-30 $4.0M 2.2M 1.83
2023-03-31 $4.4M 2.2M 1.98
2022-12-31 $0 2.2M 0.00
2022-09-30 $4.2M 2.2M 1.90
2022-06-30 $4.7M 2.2M 2.11